iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Short Interest Update

iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) was the recipient of a significant growth in short interest in the month of December. As of December 15th, there was short interest totaling 4,328 shares, a growth of 205.9% from the November 30th total of 1,415 shares. Based on an average trading volume of 1,514 shares, the short-interest ratio is presently 2.9 days. Currently, 2.9% of the company’s stock are sold short. Currently, 2.9% of the company’s stock are sold short. Based on an average trading volume of 1,514 shares, the short-interest ratio is presently 2.9 days.

iShares Neuroscience and Healthcare ETF Price Performance

Shares of NYSEARCA:IBRN traded down $0.11 during trading on Friday, reaching $32.51. 509 shares of the stock were exchanged, compared to its average volume of 792. iShares Neuroscience and Healthcare ETF has a 1-year low of $17.86 and a 1-year high of $33.32. The stock has a fifty day moving average of $30.63 and a two-hundred day moving average of $26.61. The firm has a market cap of $4.88 million, a price-to-earnings ratio of 15.61 and a beta of 0.93.

About iShares Neuroscience and Healthcare ETF

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.